Podcasts about Measure

I'm Josh Kopel, a Michelin-awarded restaurateur and the creator of the Restaurant Scaling System. I've spent decades in the industry, building, scaling, and coaching restaurants to become more profitable and sustainable. On this show, I cut through the noise to give you real, actionable strategies that help independent restaurant owners run smarter, more successful businesses.In this episode, I dive into how to market restaurants more effectively by treating each service as its own unique offering. I explain why lunch, dinner, and brunch each need clear promises and tailored marketing, and how productizing those services can transform customer acquisition. I break down the phased approach I use to launch them and the strategies that actually move the needle on performance. TakeawaysEach service is a standalone product with a single obvious promise.Lunch is not just food earlier; it's a promise of speed and certainty.Different services cater to different customer needs and experiences.Your website should route customers to the service they want.Marketing should focus on one service at a time for better results.Creating a clear offer and ritual for each service is essential.Measure the success of your marketing efforts consistently.Product market fit is crucial for customer acquisition.Awareness builds on the momentum of a strong service offering.Tailor your marketing message to fit into customers' lives.Chapters00:00 Introduction to Restaurant Marketing Strategies01:49 Understanding Different Service Times05:39 Productizing Each Service for Success08:51 Implementing and Measuring Marketing StrategiesIf you've got a marketing or profitability related question for me, email me directly at josh@joshkopel.com and include Office Hours in the subject line. If you'd like to scale the profitability of your restaurant in only 5 days, sign up for our FREE 5 Day Restaurant Profitability Challenge by visiting https://joshkopel.com.

HT2403 - Sales Are Not a Measure of Success Unless, that is, your objective with photography is to provide an income. When someone tells me it's their best-selling image, what I hear is that this is the most expected, most cliché, most common photograph they've made. This does not mean that your worst selling photograph is your most personal, most unique, most treasured photograph that you've made. Show your appreciation for our free weekly Podcast and our free daily Here's a Thought… with a donation Thanks!

In this episode, Jack Cochran and Matthew James are joined by Rob Bruce, a presales leader at Syndigo with 20 years of experience, to discuss an innovative approach to presales operations: the Pursuit Desk. Rob shares how Syndigo has built a dedicated "concierge team" that handles RFPs, security questionnaires, reference coordination, and other time-consuming tasks, freeing solutions engineers to focus on discovery, solutioning, and building customer relationships. The conversation explores how to operate at the "top of your license," the role of AI in scaling pursuit operations, and practical advice for championing similar initiatives at your organization. Thank you to Elvance for sponsoring this episode: https://elvance.io Follow Us Connect with Jack Cochran: https://www.linkedin.com/in/jackcochran/ Connect with Matthew James: https://www.linkedin.com/in/matthewyoungjames/ Connect with Rob Bruce: https://www.linkedin.com/in/robbruce/ Links and Resources Mentioned Join Presales Collective Slack: https://www.presalescollective.com/slack Book: "Selling is Hard, Buying is Harder" by Garen Hess Timestamps 00:00 Welcome 04:29 What is a Presales Concierge 11:18 Presales culture 14:00 Working at the top of your diploma 17:10 How do you justify this 21:38 As focused as an F1 team 23:32 AI and the Pursuit Desk Key Topics Covered The Pursuit Desk Concept Functions as a presales concierge handling non-customer-facing tasks Manages RFPs, InfoSec documents, NDAs, reference coordination Creates centralized control over messaging and responses Operates on a global scale with cultural sensitivity Operating at the Top of Your License Focus on discovery, creative thinking, empathetic listening, and presenting solutions Eliminate time spent on administrative tasks that don't require SE expertise Reduce context switching and multitasking to maintain flow Maximize value delivery to customers and the organization Building the Business Case Find an executive sponsor to champion the initiative Measure impact through deal win rates and velocity Consider creative budget reallocation (travel budgets, etc.) Calculate ROI based on SE productivity and reduced burnout The Role of AI in Pursuit Operations AI handles first-pass RFP responses (80% completion) Pursuit desk personalizes and adds empathy (final 20%) Machine learning analyzes past deals for pattern recognition Go/no-go scorecards based on historical data Enables scaling without proportional headcount increases Presales Culture and Values Building trust through technical expertise and genuine personality Being a "chameleon" who adapts to different buyer needs Creating an environment where people feel welcomed and valued Mentorship and knowledge sharing across teams Preventing Burnout Eliminating nights and weekends spent on RFPs Reducing stress through better task distribution Enabling SEs to focus on work they're passionate about Creating sustainable workloads that retain top talent Measuring Success Tracking time spent on each RFP or pursuit activity Correlating effort to win-loss rates Building audit trails for continuous improvement Creating dashboards for data-driven decision making  

In this special episode of The Digital Marketing Podcast, Daniel Rowles sits down with Alex Schultz, Meta's Chief Marketing Officer and Vice President of Analytics, to unpack the future of digital marketing, and why the fundamentals still matter more than ever. Alex shares lessons from his remarkable journey: from running the world's top paper airplane website to leading growth at Meta, managing multi-billion dollar ad campaigns, and now authoring the industry-defining book Click Here. With high-profile endorsements from Mark Zuckerberg, Sam Altman, Daniel Ek, and Matthew Vaughn, the book has already gettimg rave reviews, and Daniel is putting it straight onto the reading list for his students at Imperial College. Together, Daniel and Alex dig into the core principles of great marketing: how to set meaningful goals, measure true impact, build high-performance teams, and embrace AI without losing your strategic edge. In This Episode: Why Alex wrote Click Here and why the industry desperately needed a book that gets back to fundamentals, marketing measurement, and pride in the profession. The power of incrementality: How to run meaningful tests, avoid vanity metrics, and prove real value to your CEO and CFO. Why goals are not the same as metrics and how mixing them up can derail your marketing efforts. The importance of awareness:  Why most businesses fail because people simply don't know they exist. Marketing mix matters: How one newspaper mention outperformed every digital channel—and why the basics still beat the buzz. Mediocre marketing + great conversion = success: Why broken funnels kill campaigns, no matter how brilliant your creative is. How Meta builds defensible growth : What sets their marketing apart, from deep integration with product and engineering, to AI-powered insights. AI's real impact on marketing jobs: A breakdown of the three kinds of disruption AI will bring, and why the marketers who embrace it will thrive. Paper planes, transparency, and unexpected beginnings: Hear how Alex's nerdy hobby turned into a viral website, and why he publicly shares his university grades to inspire others. Key Takeaways: Get back to basics: Clear goals, good data, and fundamental models (like the funnel) still win. Measure what matters: Metrics are not goals - incrementality is everything. Focus on defensibility and scale in your marketing channels, don't waste time on things that can't grow. AI won't replace marketers - marketers who use AI will replace those who don't. Be transparent and human: Success doesn't require perfection, it requires clarity, curiosity, and continuous learning.

Can we really measure creativity in the classroom—or are we missing the bigger picture?   In this engaging episode of the Fueling Creativity in Education Podcast, hosts Dr. Matthew Worwood and Dr. Cyndi Burnett sit down with Dr. Selçuk Acar, Professor of Educational Psychology at the University of North Texas and a leading voice in creativity assessment. Together, they dive deep into the complexities of measuring creativity in educational settings, examining the ongoing debate between domain-general and domain-specific creativity, and discussing the challenges teachers face in recognizing and nurturing creative potential among students. Dr. Acar offers practical advice for educators, emphasizing the importance of open-ended, ill-defined questions to encourage creative thought, and highlights emerging tools and strategies for integrating creativity assessment directly into classroom content. A central focus of the discussion is Dr. Acar's work on MOtES, a groundbreaking new measure of original thinking that leverages AI technology to objectively and efficiently score creative responses. The conversation explores how AI is revolutionizing creativity assessment, making it more accessible and scalable in educational environments, and the broader implications this holds for teaching and learning. Dr. Acar reflects on his own formative creative experiences as both a student and educator, underscoring the lifelong value of cultivating curiosity and original thinking. Whether you're a teacher, administrator, or researcher, this episode is packed with actionable insights and inspiring perspectives on the future of creativity in schools.   Be sure to subscribe on your favorite platform and sign up for our Extra Fuel newsletter for more resources and inspiration. Visit FuelingCreativityPodcast.com for more information or email us at questions@fuelingcreativitypodcast.com.

You didn't make anything this week—and suddenly you're questioning if you're even a real artist. In this episode, I break down why we fall into the trap of tying self-worth to productivity, and how to reclaim your identity—even in the quiet seasons.In this episode:

You don't have to spend hundreds of dollars doing a DEXA Scan or InBody to know how much lean muscle mass you have...or your body fat percentage. Spren does it through an incredible app that is AS ACCURATE as DEXA.  Watch on Youtube Follow me on Instagram My coaching client testimonials Website Chapters 00:00 Introduction to Biohacking and Body Composition 04:28 The Evolution of Elite HRV to Spren 08:42 Understanding Body Metrics and Their Importance 13:19 Exploring the Android-Gynoid Ratio 17:38 Lean Mass Index and Personal Health Journeys 20:38 Understanding Body Types and Their Implications 26:57 Personalized Nutrition Plans 35:30 The Philosophy Behind Spren 36:31 Balancing Complexity and Simplicity in Health Tech 42:15 The Role of AI in Personal Coaching 44:04 The Role of AI in Personal Health Tracking 48:37 Enhancing Accountability with AI Coaching 52:19 Understanding Body Composition and Its Importance 58:18 The Future of Health Monitoring Technology 01:03:09 Accessibility and Affordability in Health Tech  

In this episode of The Modern Hairstylist Podcast, host Hunter Donia and guest Jodie Brown break down the nurture phase of your marketing funnel so new followers become first time clients. If people are finding you but not booking, this conversation shows how to keep attention, build trust, and guide the next step with simple, repeatable touchpoints. Whether you want a clearer content plan for stories and posts, a profile that earns the follow, or a more reliable channel like email to stay in front of people, you will learn where to show up and what to say so potential clients feel seen and ready to book. Key Takeaways:

Send us a textIn Part 3 of our Soul Intelligence series, apostle Tommy Miller shows us the gospel is that you are in Him. You are revealed in His person. There is no distinction; there is seamless union between you and the Creator of the universe. And when you see Him face to face, you finally get to know yourself as you're known. Message recorded live in New Philadelphia, Ohio, on Sunday, Oct. 5, 2025.For more #asheissoareweinthisworld #asheissoareweinthisworld #unveiled #conscience #sons #manifestsons #union #legacychurchoh #newcreation #jesus #church #jesuschrist #gospel #transfigured #revelator #apostle #deathless #immortality #believe #bible #creator #godisgood #grace #hope #sermonshots #sermonclips #holyspirit #love #godislove #kingdom #peace #freedom #facebook #memes #truth #inspiration #motivationalquotes #vibes #positivevibes #christ #jesuslovesyou #russellbrand #jordanbpeterson #joerogan #atm #tommymiller #soulintelligence #EQ #emotionalintelligence Get more life-changing content from the senior pastor at Legacy Church:https://linktr.ee/tommymillerLearn more about Legacy Church:https://www.legacychurchint.org/Follow us on Facebook:https://www.facebook.com/legacychurchohFollow us on YouTube: www.youtube.com/@legacychurchoh Support the show

Rev. David Augustine Greatness without Measure Isaiah 40:9-20 View the Bulletin: https://drive.google.com/file/d/1pmuhrEZLiBJrCY2Tzu9OVaUO4MgZHBp8/view?usp=sharing

This episode is sponsored by Flipping 50 Menopause Fitness Specialist. Become a health & fitness coach and l how to design workouts that balance hormones that actually get results for women in menopause. Quick Poll!

Tune in to our weekly LIVE Mastermind Q+A Podcast for expert advice, peer collaboration, and actionable insights on success in the Probate, Divorce, Late Mortgage/Pre-Foreclosure, and Aged Expired niches! Today's episode of the All The Leads Mastermind podcast dives into how consistent follow-up and automation can turn old prospects into profitable deals. The team revisits the classic 33 Touch model and unveils the new “Refresh” program, which identifies probate leads still tied to the decedent's name and reopens opportunities most competitors have forgotten. Matt shares early success with his dialing service re-engaging aged leads, while Sheila proves the power of persistence with a 2022 win after 70 calls. Kelly introduces a community probate seminar model that brings together attorneys, bankers, and service providers to build trust and future referrals. The group unpacks why older leads often convert best, from emotional timelines and family decision-making to carrying costs and seasonal pressure, and shows how automation, seminars, and strategic touches keep agents top of mind. Tune in for proven tactics to re-engage past leads, maximize ROI, and stay the trusted resource when families are finally ready to act.Key Takeaways:  - Build a long-term nurture system for probate and aged leads.  - Embrace the 33-touch framework to stay top of mind with prospects.  - Use the Refresh program to resurrect older leads and move them forward.  - Leverage a cross-functional partner panel to support clients quickly.  - Focus on asking questions to reveal real pain points and motivate action.  - Time outreach around holidays to capture decision making when families gather. - Measure response and adjust, ensuring you add value rather than pushy selling.  To learn more, visit https://www.AllTheLeads.com or call (844) 532-3369 to check how many leads are available in your market.  #RealEstateProspecting #RealEstateMarketing #LeadGeneration #FollowUpStrategyPrevious episodes: AllTheLeads.com/probate-mastermindInterested in Leads? AllTheLeads.comJoin Future Episodes Live in the All The Leads Facebook Mastermind Group:  https://facebook.com/groups/alltheleadsmastermindBe sure to check out our full Mastermind Q&A Playlist PodMatchPodMatch Automatically Matches Ideal Podcast Guests and Hosts For InterviewsSupport the show

Get featured on the show by leaving us a Voice Mail: https://bit.ly/MIPVM

This week, Fordham's president emeritus Checker Finn and Laura Hamilton of the Center for Assessment join us for a polite debate on whether school quality should be judged by more than test scores.On the Research Minute, Adam Tyner unpacks a massive study of ten million students that tracks how gender gaps in math and reading develop from kindergarten through fifth grade—and what that means for the narrative about boys and school.Recommended contentThe mixed blessing of new school measures —Chester E. Finn, Jr., Thomas B. FordhamOur assessment systems should reflect the purposes of public education —Laura Hamilton, Center for Assessment#971: A “Quality Check” on school accountability, with Tom Toch and Lynn Olson —The Education Gadfly ShowDo we know how to measure school quality? —Van Schoales, Education WeekGender Gaps in the Early Grades: Questioning the Narrative that Schools are Poorly Suited to Young Boys — Megan Kuhfeld and Margaret Burchinal, Annenberg Institute at Brown University (2025)Redshirt the boys—Richard V. Reeves for The AtlanticFeedback Welcome: Have ideas for our show? Send them to thegadfly@fordhaminstitute.org

In this episode of the Teach Different podcast, Steve Fouts is joined by Jarvis Funches. Together they explore the profound quote by Mahatma Gandhi: “The measure of a society is how it treats its weakest members.” They unpack the claim of the quote, highlighting the role of empathy in uplifting and empowering others. The dialogue also touches on the division in society and the need for unity amidst differing viewpoints. Through their discussion, they emphasize the significance of understanding and connecting with one another, regardless of political or social differences.Episode Chapters00:00 - Introduction00:10 - Introducing the Teach Different Method02:12 - Exploring Gandhi's Quote on Society05:51 - Defining Weakness and Strength09:58 - Different Perspectives on Empowerment17:01 - Unity vs. Division in Society22:33 - The Role of Empathy in Understanding27:55 - Looking Ahead: A Call for Unity28:27 - Teach Different OutroImage Source: Anefo, CC0, via Wikimedia Commons https://commons.wikimedia.org/wiki/File:Mahatma_Gandhi,_Bestanddeelnr_916-6994.jpg 

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

What does success really mean in recovery? In this powerful solo episode, Lindsey gets real about perfectionism, the fear of success vs. fear of failure, and why trying to be an "A-student" at recovery keeps you stuck. If you've ever felt like you're not trying hard enough, not far enough along, or wondered what life would look like if you actually succeeded at recovery - this episode is for you. Discover why traditional definitions of success are keeping you trapped and learn a new perspective that will transform how you approach your recovery journey. Key Topics Covered: ⚡ The perfectionist's dilemma: Why wanting recovery to be flawless keeps you stuck ⚡ Two types of fear: Fear of failure vs. fear of success in recovery ⚡ Redefining success: From what you accomplish to who you become ⚡ The pressure of "A-student recovery": Why this mindset leads to relapse ⚡ Surrender and empowerment: Research on how letting go creates better outcomes ⚡ Daily choices over gold medals: Success when no one is watching The Two Fears That Keep You Stuck: Fear of Failure "What if I don't recover?" "What if this is just who I am?" Staying in denial feels safer because you can't fail if you stay stuck Believing you'll never be successful at recovery, so why try? Fear of Success "What if I do recover? Then what?" "What would it mean for my life if I quit playing small?" "What would it mean if I fully surrendered knowing it didn't need to be perfect?" Fear of the unknown person you'll become without your eating disorder Redefining Success: Traditional (False) Definition: Professional achievements and career advancement Material worth and financial status Luxurious lifestyle and social media image Social status, influence, and popularity Body image and physical appearance True Definition of Success: Success = Who you become in the process, not what you accomplish Success equals: Growth of character Developing skills and wisdom Growing in faith Constant growth leading to happiness and contentment Becoming your best self Powerful Questions for Self-Reflection:

Jesus once told His disciples who were unsuccessful at fishing in their excursion to cast their nets in a different place—and their nets became very full. And He told His believing disciples to go global in their endeavors of being “fishers of men.” How about that? So, is your church growing in numbers? And is your church helping other churches get planted and grow elsewhere around the world? Join Kevin as we talk about expanding the net and engaging God's related key measure. // Download this episode's Application & Action questions and PDF transcript at whitestone.org.

In this episode of The Ross Simmonds Show, Ross was interviewed by Rich Brooks to debunk the myth that content marketing ends when you press publish. Together, they explore the essential strategies behind effective content distribution, including Ross's powerful framework: Repurpose, Remix, and Reshare. From leveraging AI tools like Distribution.ai to embracing video in B2B content strategy, this conversation is packed with actionable insights to help your content reach the audience it deserves. Key Takeaways and Insights: 1. The Real Work Starts After “Publish” - Publishing is not the final step—it's the starting line. - Measure not by how often you publish but by how many people you reach and engage. - Most content dies in obscurity because it's never distributed effectively. 2. What is Content Distribution, Really? - The process of ensuring your content is discovered by the right audience. - Requires deep audience and channel research to deliver content in the right format at the right place. - It's about strategy, not just amplification. 3. The Three R's Framework: Repurpose, Remix, Reshare - Repurpose: Turn one content asset (e.g. webinar) into blog posts, newsletters, eBooks. - Remix: Reformat – video into audio, cut clips for social media. - Reshare: Continuously circulate evergreen content; don't assume one post is enough. - Modernize and refresh content similar to how Disney reboots classic stories. 4. Should You Lead with Video, Audio, or Text? - Best: Video – it's the most repurposable and personal format, even in B2B. - Next: Audio – podcasting creates parasocial relationships and trust. - Last: Text – still valuable, but easier to fake and less engaging. - Embrace the format that aligns with your strength—but don't ignore video if you're serious about future visibility. 5.  Using AI To Scale Content Distribution - AI is an accelerant: great marketers get greater, fast. - AI tools like Distribution.ai help apply your brand voice and create promotional content at scale. - Human review is still critical—AI is great, but human nuance still wins. 6. SEO Is Not Dead - "SEO is dead" is a myth. Search has evolved, not vanished. - Think beyond Google: people search on LinkedIn, Reddit, YouTube, Facebook, Instagram. - Optimize for discovery wherever your audience is searching. Resources & Tools:

In this episode of Holodeck Divas we discuss the Star Trek - The Next Generation Episode "The Measure of a Man" (s2e9). This episode is widely regarded as one of the first great Next Generation episodes, and is often listed in a top 10 "best episode" list. Data is being told that he is going to be taken a part for science, with no guarantee that he can be put back together. Thus ignites a debate (and trial) over Data, and whether or not he is a sentient being. Naturally the divas take the time to insert some bad timing jokes. Listen to hear what the divas think!

We spend all of our time making sure we are checking all the boxes, doing things as expected and then trying to finish well. We measure efficiency, profitability, sales. What if instead we measured engagement, satisfaction, happiness.  It is all about placebos. Links & Resources: Host: Sean Low of The Business of Being Creative Have your own opinion on Sean's tips and advice? Talk Back!! Email Sean or record a voice message directly through his show's site! Link: Join Sean's Collective of Business Creatives Follow Sean on social media: Instagram: @SeanLow1 | Facebook: Facebook.com/Sean.Low.35 | LinkedIn | Twitter: @SeanLow — Podcast Network: The Wedding Biz Network Production House: Flint Stone Media Copyright of The Wedding Biz, LLC. 2023.

As voters consider a measure to fund public health, host Nick Preciado sits down with Santa Clara County CEO James Williams to explain the proposal and why it matters.

Not everything that drives growth shows up in Google Analytics. IIn this week's episode of Growth Talks, Matt Bahr, Co-Founder of Fairing, joins host Krystina Rubino how survey data is reshaping attribution, helping brands uncover what truly influences customer decisions in today's complex media landscape. Drawing on 15 years of experience from leading global e-commerce at Master & Dynamic to building Fairing, Matt shares why PR might matter more in an AI-driven world, how post-purchase surveys complement ad pixels, and the key strategies marketers need to move beyond the last click.  Find out how Fairing is helping leading brands turn real-time insights into smarter strategies and long-term growth.

Ops isn't just about keeping the lights on anymore.As Aušrinė Keršanskaitė, co-founder of Operations Nation, puts it – today's ops leaders are expected to drive growth, protect culture, and build resilience. And if you've ever felt like the “glue” holding everything together without always getting recognition, this one will hit home.In this episode of The Handbook: The Operations Podcast, Aušrinė joins Harv to talk about the evolution of operations, the community she's built for ops leaders everywhere, and what it takes to step into leadership with confidence.Here's what we get into:How so many of us “fall into” operations without a playbook – and how to build one for yourselfThe loneliness of ops roles, and why communities like Operations Nation matterTraits that define a brilliant ops leader today – from resilience to influence over executionHow startups' scrappy mindset can sharpen your approach to tooling, automation, and scalingThe real opportunity with AI in ops (hint: it's not about replacing your team)Whether you're a COO, head of ops, or still figuring out your path – this conversation is packed with lessons on how to elevate your role and find support along the way.Additional Resources: 

Welcome to Season 3 — I'm thrilled you're along for the ride. My mission hasn't changed: I still want to make “Cats on the Cradle” just a song, not anyone's life story. What is shifting is the toolbox. I've been a tech geek since I wrote my first program in 1980, and now AI is a giant new lever. I'm obsessed with systems because they keep us honest and sane, and one of our Core Values — purpose — anchors everything we do. This season I'll show you how to use AI without losing your soul.Here's the honest pitch: when AI gives you back 10 hours, the point isn't to cram more tasks into your calendar — it's to live. Use that time for self-care, for a real conversation with your kids, or for that hobby that reminds you who you are outside the grind. I'll walk you through practical systems that let AI be a servant, not a tyrant. Expect real strategies, a few laughs, and tangible steps to make technology serve your life, not the other way around.- AI is a tool to reclaim time, not to multiply busywork.- Build systems so your actions reflect your purpose.- Use regained hours for family, rest, and meaningful work.- Start small: experiments beat perfection when learning AI.- Let AI handle tasks; you handle relationships and judgment.- Measure results, then scale what actually moves your life forward.- Keep humanity first while you level up with technology.#LifeBalance #PurposeDriven #ThirdPower #AI #Productivity #FamilyFirst #SystemsThinkingIf you want a clear roadmap, grab my AI Ascension Guide — it walks you up the four levels: Explorer (safe first experiments), Assistant (AI as your smart intern), Agent (delegate multi-step workflows), and Commander (orchestrate an AI ecosystem). Start the guide here: https://www.thirdpowerlife.ai/ai-ascension-guide — let's get you more time, more impact, and more soul.

My guest is Dr. Poppy Crum, PhD, adjunct professor at Stanford, former Chief Scientist at Dolby Laboratories and expert in neuroplasticity—our brain's ability to change in response to experience. She explains how you can learn faster and ways to leverage your smartphone, AI and even video games to do so. We also discuss “digital twins” and the future of health technology. This episode will change the way you think about and use technology and will teach you zero-cost protocols to vastly improve your learning, health and even your home environment. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman David: https://davidprotein.com/huberman Helix: https://helixsleep.com/huberman Rorra: https://rorra.com/huberman Function: https://functionhealth.com/huberman Timestamps (0:00) Poppy Crum (2:22) Neuroplasticity & Limits; Homunculus (8:06) Technology; Environment & Hearing Thresholds; Absolute Pitch (13:12) Sponsors: David & Helix Sleep (15:33) Texting, Homunculus, Mapping & Brain; Smartphones (23:06) Technology, Data Compression, Communication, Smartphones & Acronyms (30:32) Sensory Data & Bayesian Priors; Video Games & Closed Loop Training (40:51) Improve Swim Stroke, Analytics & Enhancing Performance, Digital Twin (46:17) Sponsors: AGZ by AG1 & Rorra (49:08) Digital Twin; Tool: Learning, AI & Self-Testing (53:00) AI: Increase Efficacy or Replace Task?, AI & Germane Cognitive Load (1:02:07) Bread, Process & Appreciation; AI to Optimize Physical Environments (1:09:43) Awake States & AI; Measure & Modify (1:16:37) Wearables, Sensors & Measure Internal State; Pupil Size (Pupillometry) (1:23:58) Sponsor: Function (1:25:46) Integrative Systems, Body & Environment; Cognitive State & Decision-Making (1:32:11) Gamification, Developing Good Habits (1:38:17) Implications of AI, Diminishing Cognitive Skill (1:41:11) Digital Twins & Examples, Digital Representative; Feedback Loops (1:50:59) Customize AI; Situational Intelligence, Blind Spots, Work & Health, “Hearables” (2:01:08) Career Journey, Perception & Technology; Violin, Absolute Pitch (2:09:44) Incentives & Neuroplasticity; Technology & Performance (2:13:59) Acoustic Arms Race: Moths, Bats & Echolocation (2:21:17) Singing to Spiders, Spider Web & Environment Detection; Crickets; Marmosets (2:31:44) Acknowledgements (2:33:18) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

The Guilty Feminist 450. Shakespeare's Measure for Measure Presented by Deborah Frances-White with special guest Emily Burns Recorded 22 September 2025 at the Royal Shakespeare Theatre. Released 29 September. The Guilty Feminist theme composed by Mark Hodge. Measure for Measure is playing at the Royal Shakespeare Theatre in Stratford upon Avon until 25 October 2025. Get Deborah's new book with 30% off using the code SIXCONVERSATIONSPOD https://store.virago.co.uk/products/six-conversations-were-scared-to-have More about Deborah Frances-White ·       https://deborahfrances-white.com ·       https://www.instagram.com/dfdubz ·       https://www.virago.co.uk/titles/deborah-frances-white/six-conversations-were-scared-to-have/9780349015811 ·       https://www.virago.co.uk/titles/deborah-frances-white/the-guilty-feminist/9780349010120 More about Emily Burns and Measure for Measure ·       https://www.unitedagents.co.uk/emily-burns ·       https://www.rsc.org.uk/measure-for-measure For more information about this and other episodes… ·       visit https://www.guiltyfeminist.com ·       tweet us https://www.twitter.com/guiltfempod ·       like our Facebook page https://www.facebook.com/guiltyfeminist ·       check out our Instagram https://www.instagram.com/theguiltyfeminist ·       or join our mailing list http://www.eepurl.com/bRfSPT More Big Speeches workshops now available https://guiltyfeminist.com/big-speeches/ Come to a live show ·       Femonomics: Using Data to Improve Women's Lives, 6 October https://www.eventbrite.co.uk/e/femonomics-using-data-to-improve-womens-lives-tickets-1606840797079 ·       Cheltenham Book Festival with Poorna Ball, 11 October https://www.cheltenhamfestivals.org/events/deborah-frances-white ·       Wimbledon Book Fest with Jessica Swale, 21 October https://www.wimbledonbookfest.org/events/jessica-swale/ Thank you to our amazing Patreon supporters. To support the podcast yourself, go to https://www.patreon.com/guiltyfeminist You can also get an ad-free version of the podcast via Apple Podcasts. The Guilty Feminist is part of The AudioPlus Network. If you'd like to work with us, please get in touch at hello@weareaudioplus.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jon Hartley is a macroeconomist and affiliated scholar at the Mercatus Center. Jon returns to the show to discuss the most recent Hoover Monetary Conference, the legacy of John Taylor, why central banks should be using his new measure of r-star, the status of debt management at the US Treasury, and much more. Check out the transcript for this week's episode, now with links. Recorded on August 26th, 2025 Subscribe to David's Substack: Macroeconomic Policy Nexus Follow David Beckworth on X: @DavidBeckworth Follow Jon Hartley on X: @Jon_Hartley_ Follow the show on X: @Macro_Musings Check out our Macro Musings merch! Subscribe to David's new BTS YouTube Channel  Timestamps 00:00:00 - Intro 00:05:56 - John Taylor's Contributions to Economics 00:34:10 - Better Measure of R-Star 00:48:11 - The Government's Debt Management Policy 01:03:39 - Outro

How do we know who is a genuine believer? And why does it matter to know the difference between conversion and conviction? Those are the questions we're wrestling with in this episode How to Study the Bible. Today, we're studying Daniel 4 in our Living Right Side Up in an Upside Down World series. After dreams, miracles, and multiple warnings, the king still resists repentance—until God graciously brings him low and restores him when he finally acknowledges: “Heaven rules.” Nicole distinguishes religious conviction from Christian conversion, names how pride hides in plain sight, and calls listeners to examine their allegiance—not to personalities, parties, or echo chambers, but to Jesus as Lord. You’ll learn how to read Daniel 4 with context, spot the turn from “the tree” to “the man,” and apply the chapter’s timeless truths to your life today. Key Takeaways from Daniel 4 - Religious conviction does not equal Christian conversion. Interest, morality, or “saying the right words” is not the same as repentance and allegiance to Jesus. Heaven rules. God is sovereign over kings, kingdoms, and timelines—even when He seems slow. Pride is subtle and stubborn. It hides in control, certainty, self-reliance, and power. God opposes the proud but gives grace to the humble. God is patient. Nebuchadnezzar receives 12 months to repent—Scripture shows a God who warns, waits, and still welcomes. Read carefully. Daniel 4 shifts from describing a tree (it/its) to a person (him/his)—a textual clue that the dream is about the king himself. Escape echo chambers. Anchor teaching in Scripture, not personalities or algorithms. Measure fruit, not just words. Repentance is a turn, not a tweak. Conversion means leaving the kingdom of self for the kingdom of God—a new operating system. Recommended Resources and Next Steps - Get the free Daniel Study Guide: Daily 15-minute readings, reflection prompts, and prayer to help you engage Scripture all week. (Find it at NicoleUnice.com/daniel.) Subscribe & Review: If this helped you, follow the show and leave a quick review so others can find the podcast. Share the episode with a friend or small group studying Daniel. Watch the bonus segment on YouTube ("How Am I Meant to Operate as a Christian in a Broken, Fallen World?"): Join the conversation and get the extra content! https://www.youtube.com/nicoleunice Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

On this week's episode of Excelsior Journeys: The Road to Creativity, host & producer George Sirois sits down with the guest of honor for this weekend's Archon 48 Convention in Collinsville, Illinois, acclaimed author & producer Melinda M Snodgrass. After several years working in law, Melinda took a chance on herself and started writing. This resulted in the Star Trek novel "The Tears of the Singers," and in the next several years, Melinda would work with her friend / fellow author George R.R. Martin and their anthology series "Wild Cards," and write a spec script for Star Trek: The Next Generation that would not only become the widely acclaimed episode "The Measure of a Man," but would also bring her into the writers' room as a Story Editor for nearly two seasons. This would only be the beginning of Melinda's vast creative journey, which would take her to other television series, more books, and the silver screen. Check out all of Melinda's works on her website - including "The High Ground" and "Lucifer's War," the first installments of the Imperials series and the Carolingian series - by clicking HERE.Excelsior Journeys: The Road to Creativity exists primarily as a platform for creatives of all kinds (authors, filmmakers, stand-up comics, musicians, voice artists, painters, podcasters, etc) to share their journeys to personal success. It is very important to celebrate those voices as much as possible to not only provide encouragement to up-and-coming talent, but to say thank you to the established men & women for inspiring the current generation of artists.If you agree that the Excelsior Journeys podcast serves a positive purpose and would like to show your appreciation, you can give back to the show by clicking HERE.Excelsior Journeys: The Road to Creativity is now a proud member of the Podmatch Podcast Network, and you can access all shows in the network by clicking HERE.

In this episode, Nataraj welcomes Matt Martin, CEO of Clockwise, to explore the science of smart scheduling. Discover how Clockwise uses AI to optimize calendars, reduce meeting overload, and create more focused work time. Matt shares insights on balancing collaboration with individual productivity, the impact of remote work on meeting culture, and the future of AI-powered time management. Learn actionable strategies to transform your workday and boost your team's efficiency. Why care? Because reclaiming your time is the first step to achieving your goals.### What you'll learn- Implement AI-driven tools to analyze and optimize your schedule for peak productivity.- Balance maker and manager schedules to accommodate different work styles within your team.- Identify and eliminate unnecessary meetings to free up valuable time for focused work.- Leverage asynchronous communication methods to reduce the reliance on synchronous meetings.- Understand the impact of remote work on meeting culture and adapt your strategies accordingly.- Measure the ROI of productivity tools to ensure they are contributing to your bottom line.- Explore the potential of AI agents to automate scheduling and optimize workflows.- Discover the importance of memory and context in AI assistants for the workplace.### About the Guest and Host:Guest Name: Matt Martin, CEO of Clockwise, helping individuals and teams create smarter schedules with AI.Connect with Guest:→ LinkedIn: https://www.linkedin.com/in/voxmatt/→ Website: https://www.getclockwise.com/Nataraj: Host of the Startup Project podcast, Senior PM at Azure & Investor.→ LinkedIn: https://www.linkedin.com/in/natarajsindam/→ Twitter: https://x.com/natarajsindam→ Substack: ⁠https://startupproject.substack.com/⁠### In this episode, we cover(00:01) Introduction to Matt Martin and Clockwise(00:58) What is Clockwise and how customers use it(02:19) Optimizing meetings in organizations(02:56) Maker Schedule versus Manager Schedule(05:38) Trends in non-scheduled meetings(07:33) The shift in adopting new SaaS products(08:43) Impact of zero interest rate environment on SaaS buying(11:32) AI agents and their promises(12:49) Measuring efficiency gains with AI tools(14:14) Outcome-based pricing models(17:46) How Clockwise leverages AI in its product(20:51) MCP vs APIs(22:26) The trend of half-baked tools(24:54) Rethinking fundamental apps with AI(26:56) Adding AI features on current products(29:03) Power of products like Zapier and Enneken with AI(33:08) Categories of AI companies that are likely to succeed(36:49) AI assistant for your workplace(39:26) User interface(46:01) How to discover Matt and ClockwiseDon't forget to subscribe and leave us a review/comment on YouTube Apple Spotify or wherever you listen to podcasts.#Clockwise #AIScheduling #CalendarOptimization #ProductivityTips #TimeManagement #MeetingStrategy #RemoteWork #HybridWork #AITools #SaaS #Entrepreneurship #StartupProject #NatarajSindam #Podcast #TechInnovation #WorkflowAutomation #ArtificialIntelligence #ProductivityHacks #MattMartin

What exactly is a decibel, and why is it measured on a logarithmic scale? In this episode of The SOUND Project, Gavin breaks down the science of sound intensity, exploring how decibels work, why our ears perceive loudness the way they do, and how this knowledge applies in both studio and live sound environments.We'll cover:-The origins of the decibel and Alexander Graham Bell's connection-Why decibels are measured logarithmically-Real-world examples of decibel levels (from quiet homes to rock concerts and jet engines)-The importance of hearing protection and how filters work-How decibel changes are perceived versus measured-How multiple sound sources combine in terms of dB levelsWhether you're a mixing engineer, a live sound tech, or just curious about how loudness works, this episode gives you a solid foundation in understanding decibels.

God is always sovereign, and nothing happens unless he decrees it, but sometimes he waits to see how his children behave before he acts. Subscribe to daily devotions e-mails: https://wcm.link/ddsub

According to the New York Post, Charlie Kirk's memorial service last Sunday has racked up 20 million views and counting, not to mention the popularity of short videos with lines like “I forgive him” from Erika Kirk, “We are Charlie” from other speakers, and the many posts of “Here I am, send me” from Isaiah 6:8. As Christ-followers, the story of Charlie's death and memorial might be causing us to stop and ask, “Do I measure up to this?” Come find your answer this Sunday, as we continue our message series, Imperfect Together, and find out how to measure our maturity. You might find you're using the wrong measuring stick.

We need AI systems to synthesise new knowledge, not just compress the data they see. Jeremy Berman, is a research scientist at Reflection AI and recent winner of the ARC-AGI v2 public leaderboard.**SPONSOR MESSAGES**—Take the Prolific human data survey - https://www.prolific.com/humandatasurvey?utm_source=mlst and be the first to see the results and benchmark their practices against the wider community!—cyber•Fund https://cyber.fund/?utm_source=mlst is a founder-led investment firm accelerating the cybernetic economyOct SF conference - https://dagihouse.com/?utm_source=mlst - Joscha Bach keynoting(!) + OAI, Anthropic, NVDA,++Hiring a SF VC Principal: https://talent.cyber.fund/companies/cyber-fund-2/jobs/57674170-ai-investment-principal#content?utm_source=mlstSubmit investment deck: https://cyber.fund/contact?utm_source=mlst— Imagine trying to teach an AI to think like a human i.e. solving puzzles that are easy for us but stump even the smartest models. Jeremy's evolutionary approach—evolving natural language descriptions instead of python code like his last version—landed him at the top with about 30% accuracy on the ARCv2.We discuss why current AIs are like "stochastic parrots" that memorize but struggle to truly reason or innovate as well as big ideas like building "knowledge trees" for real understanding, the limits of neural networks versus symbolic systems, and whether we can train models to synthesize new ideas without forgetting everything else. Jeremy Berman:https://x.com/jerber888TRANSCRIPT:https://app.rescript.info/public/share/qvCioZeZJ4Q_NlR66m-hNUZnh-qWlUJcS15Wc2OGwD0TOC:Introduction and Overview [00:00:00]ARC v1 Solution [00:07:20]Evolutionary Python Approach [00:08:00]Trade-offs in Depth vs. Breadth [00:10:33]ARC v2 Improvements [00:11:45]Natural Language Shift [00:12:35]Model Thinking Enhancements [00:13:05]Neural Networks vs. Symbolism Debate [00:14:24]Turing Completeness Discussion [00:15:24]Continual Learning Challenges [00:19:12]Reasoning and Intelligence [00:29:33]Knowledge Trees and Synthesis [00:50:15]Creativity and Invention [00:56:41]Future Directions and Closing [01:02:30]REFS:Jeremy's 2024 article on winning ARCAGI1-pubhttps://jeremyberman.substack.com/p/how-i-got-a-record-536-on-arc-agiGetting 50% (SoTA) on ARC-AGI with GPT-4o [Greenblatt]https://blog.redwoodresearch.org/p/getting-50-sota-on-arc-agi-with-gpt https://www.youtube.com/watch?v=z9j3wB1RRGA [his MLST interview]A Thousand Brains: A New Theory of Intelligence [Hawkins]https://www.amazon.com/Thousand-Brains-New-Theory-Intelligence/dp/1541675819https://www.youtube.com/watch?v=6VQILbDqaI4 [MLST interview]Francois Chollet + Mike Knoop's labhttps://ndea.com/On the Measure of Intelligence [Chollet]https://arxiv.org/abs/1911.01547On the Biology of a Large Language Model [Anthropic]https://transformer-circuits.pub/2025/attribution-graphs/biology.html The ARChitects [won 2024 ARC-AGI-1-private]https://www.youtube.com/watch?v=mTX_sAq--zY Connectionism critique 1998 [Fodor/Pylshyn]https://uh.edu/~garson/F&P1.PDF Questioning Representational Optimism in Deep Learning: The Fractured Entangled Representation Hypothesis [Kumar/Stanley]https://arxiv.org/pdf/2505.11581 AlphaEvolve interview (also program synthesis)https://www.youtube.com/watch?v=vC9nAosXrJw ShinkaEvolve: Evolving New Algorithms with LLMs, Orders of Magnitude More Efficiently [Lange et al]https://sakana.ai/shinka-evolve/ Deep learning with Python Rev 3 [Chollet] - READ CHAPTER 19 NOW!https://deeplearningwithpython.io/

September 27th, 2025: Ss Cosmas & Damian - Sanctifying Daily Life; St Vincent de Paul, Apostle of Charity; God is the Measure of Glory; Servant of God Mary Emmanuela; Ss Cosmas & Damian - Martyrdom, the Supreme Witness of Our Faith

On this Make A Difference Minute, I'm reflecting on what truly matters at the end of our lives. Success, recognition, and possessions may capture our attention now, but they will not define our legacy. What lasts is the kindness we showed, the love we gave, and the difference we made in the lives of others. This segment encourages listeners to live with perspective today, building a meaningful life marked by compassion and service. Sponsor: Hydration Lounge HydrationL.com

Measuring SEO efforts can feel heavy, no? There are several other podcast episodes where I walk through specific metrics and where to find them, but in this one, I want to talk more about how to connect these metrics to things that actually make sense for you and your business. In this episode, we cover: What return you can expect from your SEO How to fit your Search Marketing with your business goals How often you should be looking at your SEO results Listen + read shownotes for this podcast episode here: https://digitalbloomiq.com/seo/how-to-measure-seo-efforts More podcast episodes here: https://digitalbloomiq.com/podcast Follow Digital Bloom IQ on Instagram: https://instagram.com/digitalbloomiq Website Links: Get email updates on all podcast episodes (+ SEO tips, behind the scenes, and early bird offers) : here: https://digitalbloomiq.com/email   90 Day SEO Plan: Your Dream Clients Booking You Overnight! Free webinar training here: https://digitalbloomiq.com/90dayseoplan More information about the podcast and Digital Bloom IQ: https://digitalbloomiq.com/podcast https://www.instagram.com/digitalbloomiq/ https://twitter.com/digitalbloomiq https://facebook.com/digitalbloomiq https://www.linkedin.com/in/cinthia-pacheco/ Voice Over, Mixing and Mastering Credits: L. Connor Voice - LConnorvoice@gmail.com Lconnorvoice.com Music Credits:  Music: Kawaii! - Bad Snacks Support by RFM - NCM: https://bit.ly/3f1GFyN  

Ben Smith, Marketing Director at Reachdesk, shares his journey from professional ice skater to marketing leader and dives into the power of gifting in B2B. He explains how Reachdesk helps businesses source, personalize, and automate gifting at a global scale, and why combining physical and digital experiences creates deeper customer connections. Ben also discusses Reachdesk's marketing strategy, the role of AI in modern marketing, and why personalization, creativity, and genuine relationship building are key to successful outreach.   About Ben Meet Ben Smith, a dynamic marketing leader with a passion for driving strategic growth and creative impact. As a seasoned professional at Reachdesk, he's helped brands build stronger connections, unlock new opportunities, and deliver customer experiences that truly engage. Known for translating big ideas into measurable results, Ben shares actionable insights on outbound and allbound strategies — from sparking pipeline to scaling engagement. Join us as he brings fresh perspectives and stories from the cutting edge of modern marketing.   About ReachDesk At Reachdesk, we believe that strong relationships fuel success. Whether you're engaging prospects, celebrating customers, or recognizing employees, our platform makes it simple to deliver personalized moments that resonate at scale. As the only fully integrated gifting and swag solution, we empower go-to-market and people teams to: Strengthen connections with prospects, customers, and employees. Remove operational headaches with a seamless global fulfilment network. Measure the impact of every send, so gifting becomes a strategic advantage, not just a nice-to-have.   Time Stamps 00:00:00 - Introduction to Marketing B2B Tech Podcast 00:00:18 - Guest Introduction: Ben Smith from Reachdesk 00:00:41 - Ben's Unique Career Journey 00:01:42 - What Reachdesk Does 00:02:31 - Challenges of International Shipping 00:03:15 - The Importance of Physical Gifts in a Digital World 00:04:30 - Customer Use Cases for Reachdesk 00:05:55 - Navigating Gifting Mistakes and Concerns 00:07:36 - The Philosophy of Gifting in Marketing 00:09:02 - Marketing Strategies at Reachdesk 00:11:35 - Building Brand Reputation vs. Driving Leads 00:13:04 - Influencer Marketing in B2B 00:15:05 - Understanding the Buying Committee 00:18:00 - Identifying Gifting Touchpoints in the Customer Journey 00:22:04 - The Impact of Technology on Marketing 00:25:21 - Advice for New Marketing Professionals   Follow Ben: Ben Smith on LinkedIn: https://www.linkedin.com/in/bensmith-reachdesk/ Reachdesk website: https://www.reachdesk.com/ Reachdesk on LinkedIn: https://www.linkedin.com/company/reachdesk/   Follow Mike: Mike Maynard on LinkedIn: https://www.linkedin.com/in/mikemaynard/ Napier website: https://www.napierb2b.com/ Napier LinkedIn: https://www.linkedin.com/company/napier-partnership-limited/ If you enjoyed this episode, be sure to subscribe to our podcast for more discussions about the latest in Marketing B2B Tech and connect with us on social media to stay updated on upcoming episodes. We'd also appreciate it if you could leave us a review on your favourite podcast platform. Want more? Check out Napier's other podcast – The Marketing Automation Moment: https://podcasts.apple.com/ua/podcast/the-marketing-automation-moment-podcast/id1659211547

Stay Connected:Facebook:  / pearlchurchdenver  Instagram:  / thepearlchurch  __________________________________________________________________Doug and Donna have long been considered two of the most respected youth pastors in America. They have given their lives to seeing people radically transformed by the message of Christ. Their deep roots in ministry began in Portland, Oregon where they served for 17 years as Executive Pastors and Generation Ministry Directors under Pastor Frank Damazio at City Bible Church.___________________________________________________________VISION STATEMENT:“Our vision is to build a vibrant, life giving Church for this generation in the Denver Metro area, where people of all races, backgrounds, and socio-eco status, can experience God's grace, rally in community, and champion the cause of Christ together.”

Brian McCormack is in for the ill Ryan, the guys discuss height, Danny Webster's abs and Brian gets distracted by hockey near the end.

Other Episodes You Might Like: Previous Episode - 5 Ways to Measure & Improve Your Menopause Fitness At Home Right Now Next Episode - 5 Things I Do When I Need a Reset or I've Had a Fitness Plateau More Like This - Turning Your Personal Drama and Trauma into Transformation   Resources: Don't know where to start? Book your Discovery Call with Debra. Join the Flipping50 Insiders Group in Facebook to connect with Debra and other podcast listeners.   Are you doing all the right things but aren't working in menopause? What is it beyond exercise, hormones and supplements? I was at a women's retreat in a sound healing. During the session, I experienced tears and came back to the circle after realizing I thought of my biological father during that session. I hadn't thought about him over the years much at all. Is that stored trauma? Is stored trauma something we all deal with on some level? Is it something that could be limiting our ability to reach a physical health or fitness goal. Is it related to what is blocking our ability to lose weight, to heal our gut, or on a bigger level is it putting us at risk for more serious health issues? We're unpacking all of this today. If all the right things aren't working in menopause, it may go beyond hormones and gut health.    My Guest: Dr. Aimie Apigian is a leading expert in trauma, attachment, and biology, and the founder of the Biology of Trauma™. She integrates her medical expertise with specialized training in trauma therapy to address the biological patterns that maintain chronic health conditions. Through her programs and upcoming book "The Biology of Trauma: How the Body Experiences and Holds Pain, Fear and Overwhelm and How to Heal," Dr. Aimie helps people understand why common health issues persist despite perfect nutrition and lifestyle changes, and provides practical tools for complete healing at the cellular level.   Connect with Dr. Aimie: Book - Biology of Trauma  Facebook Group - Biology of Trauma Instagram - @draimie   Questions We Answer in This Episode: [00:06:22] Do we have to remember something traumatic for it to actually have happened to us? [00:07:57] Are both physical and emotional traumas the same in the way they manifest in the body? What is trauma? [00:14:32] Many women in midlife experience unexplained weight gain, fatigue, or hormone issues despite 'doing everything right.' Are you saying past trauma is contributing to these challenges? [00:22:53] Is there a "too late" when it comes to healing the body from these early experiences? What does stored trauma look like inside the body physiologically? [00:28:41] What are the steps to address trauma impacting body composition for women in midlife — like belly fat that "won't budge" despite good habits? [00:33:25] How do you help strong, independent women recognize that “pushing through” might sometimes be prolonging unresolved trauma patterns in the body? [00:35:13] What attachment patterns from childhood can affect our health into adulthood? [00:41:04] If you could tell every 50-something woman one thing about the link between her past experiences and her future vitality, what would it be?

Nine years ago, Union County voters overwhelmingly voted to pass Measure 31-89, which limited county commissioners to two terms, or eight years, in office. A whopping 68% of voters supported the change, which came from Union County Citizens for Good Government. Now, more than eight years after the measure took effect, Union County Commissioners will no longer be limited by term limits. In January, the county commissioners unanimously voted to have the measure brought to the courtroom, requesting the circuit court to examine the constitutionality of the measure. Earlier this month, County Clerk Lisa Feik shared that the court ruled in favor of the commissioners, ending term limits. Union County Commissioner Paul Anderes joins us to share why he and his fellow commissioners voted to bring this measure to the courts. We’ll also hear from Jim Mollerstrom, the former organizer for Union County Citizens for Good Government, to share why he was pushing for this initially and his thoughts on the change.

Admin & Tech isn't flashy like enrollment or emotional like staff culture—but it's one of the biggest hidden profit drains in schools. In this finale of the Money Leaks series, Chanie breaks down how underutilized software, paper-based SOPs, missing automations, and messy file systems quietly torch your time capacity and cash. You'll get a simple, CEO-level playbook to audit your tech stack, automate the right tasks, assign platform “champions,” and build rhythms that stop dependency and start true scalability.

On Healthy Waves with host Avik Chakraborty, board-certified neurologist and Navy veteran Dr. Ryan Williamson breaks down what actually extends lifespan and healthspan. He rejects hype and quick fixes, and shows how four evidence-backed pillars—sleep quality, daily movement, smart nutrition, and effective stress management—protect the brain, sharpen cognition, and reduce all-cause mortality. We also cover wearable tracking (e.g., sleep), circadian rhythm and morning light, VO₂ max and strength training, and how purpose and meaning anchor sustainable habits. If you want a practical, science-first roadmap to longevity and cognitive performance, this conversation is for you. About the Guest  : Ryan Williamson, MD is a board-certified neurologist, proud Navy veteran, and founder of Transcend Health. His mission: help people optimize cognitive performance, prevent chronic disease, and live lives of meaning and impact. He is the author of The Incredible Brain. Key Takeaways : Longevity is mostly behavioral: 70–90% of outcomes relate to daily choices across sleep, movement, nutrition, and stress. Movement first. Morning light + a short walk sets circadian rhythm, boosts daytime alertness, and supports deeper sleep at night. Measure sleep, don't guess. Wearables (e.g., a ring tracker) can reveal how meals, alcohol, and routines change deep sleep, HR, and HRV. Strength + cardio both matter. VO₂-max work and resistance training independently correlate with lower all-cause mortality and better brain health. Nutrition is foundational. Emphasize fiber and healthy fats; avoid overcomplication and product-driven advice lacking evidence. Stress skills are non-negotiable. Simple, repeatable practices (breath, boundaries, recovery windows) reduce cognitive load and inflammation. Purpose drives consistency. Clarifying meaning makes habit adherence easier than chasing biohacks. Beware misinformation. Filter sources by credentials, scientific grounding, and conflicts of interest before acting. Connect with the Guest   Website: TranscendHealthGroup.com (find links to the book The Incredible Brain and social channels there) Want to be a guest on Healthy Mind, Healthy Life? DM on PM - Send me a message on PodMatch DM Me Here: https://www.podmatch.com/hostdetailpreview/avik Disclaimer: This video is for educational and informational purposes only. The views expressed are the personal opinions of the guest and do not reflect the views of the host or Healthy Mind By Avik™️. We do not intend to harm, defame, or discredit any person, organization, brand, product, country, or profession mentioned. All third-party media used remain the property of their respective owners and are used under fair use for informational purposes. By watching, you acknowledge and accept this disclaimer.   Healthy Mind By Avik™️ is a global platform redefining mental health as a necessity, not a luxury. Born during the pandemic, it's become a sanctuary for healing, growth, and mindful living. Hosted by Avik Chakraborty—storyteller, survivor, wellness advocate—this channel shares powerful podcasts and soul-nurturing conversations on: • Mental Health & Emotional Well-being• Mindfulness & Spiritual Growth• Holistic Healing & Conscious Living• Trauma Recovery & Self-Empowerment With over 4,400+ episodes and 168.4K+ global listeners, join us as we unite voices, break stigma, and build a world where every story matters.

From the archive: This episode was originally recorded and published in 2022. Our interviews on Entrepreneurs On Fire are meant to be evergreen, and we do our best to confirm that all offers and URL's in these archive episodes are still relevant. Clay is a frequent EOFire guest, former United States Small Business Administration Entrepreneur of the Year Award Winner, author, a master of scale, and business growth coach. Stephanie is a long-time EOFire listener who Clay has helped to grow her business by 1,462 percent. Top 3 Value Bombs 1. The quality of the team you have is the quality of the dream you get to live. 2. Act. Measure. Refine. 3. You have to simultaneously learn and apply. Be hopeful, yet realistic. Dream while measuring. Schedule your free 13-point assessment with Clay - Thrive Time Show Sponsors HighLevel - The ultimate all-in-one platform for entrepreneurs, marketers, coaches, and agencies. Learn more at HighLevelFire.com. Thrivetime Show - Attend the world's highest rated business growth workshop taught personally by Clay Clark and featuring Football Star and Entrepreneur, Tim Tebow and President Trump's Son Eric Trump at ThrivetimeShow.com/eofire.